Naturex Acquires Burgundy Botanical Extracts

Burgundy's addition to the Group along with its complementary product portfolio (active substance master files, new botanical extracts, active ingredients) will enable Naturex to strengthen its industrial base and capacities to meet customer needs by developing its expertise in nutraceutical, pharmaceutical and personal care.

Oct 24 2011 --- Naturex has announced the acquisition of Burgundy Botanical Extracts, a French manufacturer and supplier of plant extracts for the nutraceutical, pharmaceutical and cosmetics industries.

A European player in natural chemicals with twelve years of expertise in botanical extracts, combined with a knowledge of medicinal plants and phytochemistry/biochemistry, Burgundy is one of the European leaders in this market. Burgundy employs around 60 people at its two production sites based in France (Reyssouze - Department of Ain) and Spain (Palafolls) with significant capacity for extraction, purification and drying operations. Burgundy has three major markets and a service activity that had total revenue of EUR14 million over the last twelve months. Innovative concepts such as UTIrose, IridoForce are among the company's most well-known brands. Its manufacturing facilities have the capacity to produce concentrated or purified extracts in powder or liquid forms.

Flagship brands and products developed by Burgundy over the last 10 years include grape seed and cranberry extracts, UTIrose, a patented hibiscus extract for use in combating urinary infections and Iridoforce, an extract of harpagophytum used in the prevention of arthrosis and joint diseases.

Burgundy's addition to the Group along with its complementary product portfolio (active substance master files, new botanical extracts, active ingredients) will enable Naturex to strengthen its industrial base and capacities to meet customer needs by developing its expertise in nutraceutical, pharmaceutical and personal care.

Burgundy's products will in turn benefit from Naturex's industrial and technological expertise in addition to its global sourcing capacity, innovation and the strength of its worldwide commercial network.

"This acquisition fits perfectly with Naturex's strategy for pursuing growth in its different markets. It is an excellent development opportunity in terms of both manufacturing capacity and commercial positioning", commented Jacques Dikansky, Naturex's Chairman-CEO and founder. "With our successful track record in integrating companies and the promising potential for synergies and cross-selling from this merger, we are confident in our ability to generate sustainable profitable growth, creating value for our customers, employees and investors."

Christophe Magnin, Chairman of Burgundy added: "Combining the forces of Burgundy with Naturex will contribute to developing the industrial and scientific strengths of both these two entities. Naturex's proactive commercial network will promote greater customer proximity and enhance service quality."